Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Blood Immune Cell Analysis Detects Parkinson’s Before Symptoms Appear

By LabMedica International staff writers
Posted on 07 Nov 2025

Early diagnosis of Parkinson’s disease remains one of the greatest challenges in neurology. More...

The condition, which affects nearly 12 million people globally, is typically identified only after significant neurological damage has already occurred, often when tremors and other motor symptoms become visible. Now, a research team has developed a genetic blood analysis method that may help detect the disease before symptoms appear.

In a new study, scientists from the Miguel Hernández University of Elche (UMH, Elche, Spain) along with collaborators used standard laboratory equipment already available in many hospitals to analyze peripheral blood mononuclear cells (PBMCs) from newly diagnosed patients and healthy volunteers. The sequencing and bioinformatics analysis identified 22 genes with altered activity in Parkinson’s patients—many linked to immune response, inflammation, molecular transport, and iron homeostasis, processes previously implicated in neurodegeneration.

These findings, published in Neurotherapeutics, suggest that genetic changes in immune cells could serve as early biomarkers of Parkinson’s disease and may reveal underlying biological mechanisms that drive its onset and progression. The study also detected shifts in pathways related to cell survival, inflammation, and programmed cell death, offering new molecular insights into disease evolution.

The exploratory study included 23 patients with Parkinsonism and 16 healthy controls. Although the sample size was small, the results are consistent with independent studies conducted in Italy and the United States, reinforcing the potential of blood-based molecular diagnostics for early Parkinson’s detection.

“Until recently, the only definitive diagnosis came from post-mortem tissue analysis, but it is crucial to develop fast, minimally invasive methods that detect the disease earlier,” said UMH Professor Jorge Manzanares, who led the study.

Related Links:
UMH


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.